Mifloksan Indications/Uses

MIFLOKSAN ophthalmic solutions is indicated for the treatment of bacterial keratitis caused by susceptible strains of the following organism: Aerobic Gram-positive Microorganisms: Corynebacterium species; Micrococcus luteus (including erythromycin, gentamicin, tetracycline, and/or trimethoprim resistant strains); Staphylococcus aureus (including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline, and/or trimethoprim resistant strains); Staphylococcus epidermidis (including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline, and/or trimethoprim resistant strains); Staphylococcus haemolyticus (including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline, and/or trimethoprim resistant strains); Staphylococcus hominis (including methicillin, erythromycin, gentamicin, ofloxacin, tetracycline, and/or trimethoprim resistant strains); Staphylococcus warneri (including erythromycin resistant strains); Staphylococcus pneumoniae (including penicillin, erythromycin, gentamicin, tetracycline and/or trimethoprim resistant strains); Streptococcus viridans group (including penicillin, erythromycin, tetracycline, and/or trimethoprim resistant strains).
Aerobic Gram-negative Microorganisms: Acinetobacter lwoffii; Haemophilus influenzae (including ampicillin resistant strains); Haemophilus parainfluenzae.
Other Microorganisms: Chlamydia trachomatis.